scholarly journals STUDY ON THE GENETIC PREDISPOSITION TO BREAST CANCER AND THE DNA DAMAGE RESPONSE AT TELOMERES AND IN CELLULAR SENESCENCE

Author(s):  
Francesca Rossiello, et al. (#)

Germ line mutations in the coding sequence of some genes, mainly BRCA1 and BRCA2, confer a high risk of developing breast cancer. However, about 70% of tumors cases are not associated with any known mutation. By screening by sequencing peripheral blood of patients and healthy controls, we identified some previously unknown germline mutations in the 3 'UTR non-coding region of the BRCA1 gene. These mutations can modify gene expression, and can therefore be useful to predict, with greater accuracy, familiar breast cancer predisposition. Subsequently, to understand the mechanisms of aging in non-proliferating cells we studied the persistent DNA damage response (DDR) signal in senescent cells, both in cell cultures and in animal tissues, and we found that these signals mainly localize to telomeres, independently from their length. The accumulation of damage at the telomeric DNA, due to the inhibition of the repair mechanisms, causes cellular and individual aging, but it is also an important anti-tumor mechanism, as it prevents the uncontrolled cell growth during the early stages of neoplastic transformation.

2018 ◽  
Author(s):  
Shane R. Stecklein ◽  
Adam R. Wolfe ◽  
Bisrat G. Debeb ◽  
Richard A. Larson ◽  
Wendy A. Woodward

2018 ◽  
Author(s):  
Laura A. Baker ◽  
Christoph Krisp ◽  
Daniel Roden ◽  
Holly Holliday ◽  
Sunny Z. Wu ◽  
...  

AbstractBasal-like breast cancer (BLBC) is a poorly characterised, heterogeneous disease. Patients are diagnosed with aggressive, high-grade tumours and often relapse with chemotherapy resistance. Detailed understanding of the molecular underpinnings of this disease is essential to the development of personalised therapeutic strategies. Inhibitor of Differentiation 4 (ID4) is a helix-loop-helix transcriptional regulator required for mammary gland development. ID4 is overexpressed in a subset of BLBC patients, associating with a stem-like poor prognosis phenotype, and is necessary for the growth of cell line models of BLBC, through unknown mechanisms. Here, we have defined a molecular mechanism of action for ID4 in BLBC and the related disease highgrade serous ovarian cancer (HGSOV), by combining RIME proteomic analysis and ChIP-Seq mapping of genomic binding sites. Remarkably, these studies have revealed novel interactions with DNA damage response proteins, in particular, mediator of DNA damage checkpoint protein 1 (MDC1). Through MDC1, ID4 interacts with other DNA repair proteins (γH2AX and BRCA1) at fragile chromatin sites. ID4 does not affect transcription at these sites, instead binding to chromatin following DNA damage and regulating DNA damage signalling. Clinical analysis demonstrates that ID4 is amplified and overexpressed at a higher frequency in BRCA1-mutant BLBC compared with sporadic BLBC, providing genetic evidence for an interaction between ID4 and DNA damage repair pathways. These data link the interactions of ID4 with MDC1 to DNA damage repair in the aetiology of BLBC and HGSOV.


2020 ◽  
Vol 1867 (8) ◽  
pp. 118716 ◽  
Author(s):  
Eduardo A. Sagredo ◽  
Alfredo I. Sagredo ◽  
Alejandro Blanco ◽  
Pamela Rojas De Santiago ◽  
Solange Rivas ◽  
...  

Oncogene ◽  
2009 ◽  
Vol 28 (16) ◽  
pp. 1843-1852 ◽  
Author(s):  
J Nikkilä ◽  
K A Coleman ◽  
D Morrissey ◽  
K Pylkäs ◽  
H Erkko ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document